<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00027079</url>
  </required_header>
  <id_info>
    <org_study_id>NIAAAJOH12964</org_study_id>
    <nct_id>NCT00027079</nct_id>
  </id_info>
  <brief_title>Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</source>
  <brief_summary>
    <textblock>
      This study will compare the effectiveness of ondansetron (Zofran) and naltrexone (ReVia) both
      alone and in combination in treating Early Onset Alcoholics versus Late Onset Alcoholics. All
      subjects will received standardized Cognitive Behavioral Therapy. Followup assessments will
      be completed at 1, 3, 6, and 9 months after treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">August 2004</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>360</enrollment>
  <condition>Alcoholism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ondansetron (Zofran)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>naltrexone (ReVia)</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Current diagnosis of alcohol dependence.

          -  Provide a written informed consent.

          -  Must weigh within 30% of their ideal body weight.

          -  Patients must weigh at least 89 lbs. and no more than 342 lbs.

          -  Good physical health.

          -  Currently drinking 14 or more alcohol units per week for women and 21 or more alcohol
             units per week for men in the last 30 days.

          -  Provide evidence of stable residence in the last month prior to enrollment in the
             study.

          -  No plans to move in the nine months after entering the study.

          -  Literate in English and able to read, understand, and complete questionnaires and
             follow instructions.

          -  Willingness to participate in behavioral treatment for alcoholism.

        Exclusion Criteria:

          -  Current psychiatric disorder other than alcohol or nicotine dependence.

          -  Elevated liver enzymes or elevated bilirubin.

          -  Severe alcohol withdrawal symptoms which require treatment.

          -  Serious medical co-morbidity requiring medical intervention or close supervision.

          -  Severe or life-threatening adverse reactions to medications in the past or during this
             trial.

          -  Female patients who are pregnant, lactating, or not adhering to an acceptable form of
             contraception at any time during the study.

          -  Received inpatient or outpatient treatment for alcohol dependence within the last 30
             days.

          -  Compelled to participate in an alcohol treatment program for alcohol dependence to
             maintain their liberty.

          -  Members of the same household.

          -  Tuberculosis.

          -  Current treatment with any medications having a potential effect on alcohol
             consumption and related behaviors or mood.

          -  Urine must be free of opiates, cocaine, amphetamines, barbiturates, benzodiazepines,
             prescription and non-prescription drugs.

          -  Pyrexia of unknown origin.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2001</study_first_submitted>
  <study_first_submitted_qc>November 20, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2001</study_first_posted>
  <last_update_submitted>December 7, 2007</last_update_submitted>
  <last_update_submitted_qc>December 7, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naltrexone</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

